Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill
Charles N. Zawatsky
, Sara Mills-Huffnagle
, Corinne M. Augusto
,
Kent E. Vrana
,
Jennifer E. Nyland
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Penn State Neuroscience Institute
Social Science Research Institute (SSRI)
Consortium on Substance Use and Addiction
Department of Molecular and Precision Medicine
Department of Neuroscience and Experimental Therapeutics
Research output
:
Contribution to journal
›
Review article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cannabinoids
100%
Designer Drugs
100%
Drug Markets
100%
Farm Bill
100%
Cannabidiol
100%
Selling
23%
Δ9-tetrahydrocannabinol (Δ9-THC)
15%
Pharmacology
15%
Tetrahydrocannabinol
15%
Side Chain
7%
Consumer Interest
7%
Pulmonary Toxicity
7%
Agonist Activity
7%
Cannabinoid Receptor 1 (CB1R)
7%
Synthetic Routes
7%
U.S. Agriculture
7%
Health Crisis
7%
Synthetic Cannabinoids
7%
Deacetylation
7%
Epidemiological Findings
7%
Vaping
7%
Regulatory Oversight
7%
Legal Market
7%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Market
100%
Designer Drug
100%
Cannabidiol
100%
Cannabinoid
100%
Tetrahydrocannabinol
14%
Lung Toxicity
7%
Acetic Acid Derivative
7%
Cannabinoid 1 Receptor
7%